Cover Image

MMP-3 Contributes to Nigrostriatal Dopaminergic Neuronal Loss, BBB Damage, and Neuroinflammation in an MPTP Mouse Model of Parkinson's Disease

The present study examined whether matrix metalloproteinase-3 (MMP-3) participates in the loss of dopaminergic (DA) neurons in the nigrostriatal pathway in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease with blood brain barrier (BBB) damage and infiltra...

Full description

Saved in:

Bibliographic Details
Main Authors:	Young Cheul Chung (Author), Yoon-Seong Kim (Author), Eugene Bok (Author), Tae Young Yune (Author), Sungho Maeng (Author), Byung Kwan Jin (Author)
Format:	Book
Published:	Hindawi Limited, 2013-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's disease
by: Xavier ed'Anglemont De Tassigny, et al.
Published: (2015)

Nicotine alleviates MPTP-induced nigrostriatal damage through modulation of JNK and ERK signaling pathways in the mice model of Parkinson's disease
by: Sisi Ruan, et al.
Published: (2023)

Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP
by: Juan M. Viveros-Paredes, et al.
Published: (2017)

Vitexin protects dopaminergic neurons in MPTP-induced Parkinson’s disease through PI3K/Akt signaling pathway
by: Hu M, et al.
Published: (2018)

Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences
by: Giulia Costa, et al.
Published: (2021)

Neutral Sphingomyelinase Behaviour in Hippocampus Neuroinflammation of MPTP-Induced Mouse Model of Parkinson's Disease and in Embryonic Hippocampal Cells
by: Samuela Cataldi, et al.
Published: (2017)

CD44 deficiency represses neuroinflammation and rescues dopaminergic neurons in a mouse model of Parkinson's disease
by: Yuejun Wang, et al.
Published: (2022)

Voltage-Gated Proton Channel Hv1 Regulates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson's Disease Models
by: Matthew L. Neal, et al.
Published: (2023)

Batryticatus Bombyx Protects Dopaminergic Neurons Against MPTP-Induced Neurotoxicity by Inhibiting Oxidative Damage
by: Hye-Sun Lim, et al.
Published: (2019)

Neuroprotective effects of Neurotrophin-3 in MPTP-induced zebrafish Parkinson's disease model
by: Noor Azzizah Omar, et al.
Published: (2023)

Corynoxine Protects Dopaminergic Neurons Through Inducing Autophagy and Diminishing Neuroinflammation in Rotenone-Induced Animal Models of Parkinson's Disease
by: Leilei Chen, et al.
Published: (2021)

Compound Dihuang Granule Inhibits Nigrostriatal Pathway Apoptosis in Parkinson's Disease by Suppressing the JNK/AP-1 Pathway
by: Li Wang, et al.
Published: (2021)

Melatonin Attenuates Neuroinflammation by Down-Regulating NLRP3 Inflammasome via a SIRT1-Dependent Pathway in MPTP-Induced Models of Parkinson’s Disease
by: Zheng R, et al.
Published: (2021)

Corrigendum: Compound Dihuang Granule inhibits nigrostriatal pathway apoptosis in Parkinson's disease by suppressing the JNK/AP-1 pathway
by: Li Wang, et al.
Published: (2023)

Non-Dopaminergic Systems in Parkinson's Disease
Published: (2020)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease
by: Sara Redenšek, et al.
Published: (2019)

Intranasal mucoadhesivemicroemulsion for neuroprotective effect of curcuminin mptp induced Parkinson model
by: Snigdha Das Mandal, et al.
Published: (2017)

Parkinson's disease, dopaminergic drugs and the plant world
by: Peter Kempster, et al.
Published: (2022)

Editorial: Non-Dopaminergic Systems in Parkinson's Disease
by: Cristina Miguelez, et al.
Published: (2020)

Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
by: Tomás González-Hernández, et al.
Published: (2010)

Anti-Inflammatory Effects of the Novel Barbiturate Derivative MHY2699 in an MPTP-Induced Mouse Model of Parkinson's Disease
by: Seulah Lee, et al.
Published: (2021)

NF-κB signaling contributes to the inhibitory effects of Bombyx batryticatus on neuroinflammation caused by MPTP toxicity
by: Hye-Sun Lim, et al.
Published: (2021)

Zingiber officinale Roscoe extract improves nigrostriatal dopaminergic activity in rotenone-induced Parkinsonian mice: Implication of COX-2/TNF-α/IL-6 and antioxidant enzyme crosstalk in the immunoinflammatory responses
by: Olusegun G. Adebayo, et al.
Published: (2024)

PARKINSON'S DISEASE: ANIMAL MODELS AND DOPAMINERGIC CELL VULNERABILITY
by: Javier eBlesa, et al.
Published: (2014)

Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson's disease
by: Yaozhen Wang, et al.
Published: (2018)

Astrocytic Nrf2 Mediates the Neuroprotective and Anti-Inflammatory Effects of Nootkatone in an MPTP-Induced Parkinson's Disease Mouse Model
by: Jung-Eun Park, et al.
Published: (2023)

Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update
by: Lars eBrichta, et al.
Published: (2014)

Astragalus injection ameliorates lipopolysaccharide-induced cognitive decline via relieving acute neuroinflammation and BBB damage and upregulating the BDNF-CREB pathway in mice
by: Ke Liu, et al.
Published: (2022)

Correction: Viveros-Paredes et al. Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP. <i>Pharmaceuticals</i> 2017, <i>10</i>, 60
by: Juan M. Viveros-Paredes, et al.
Published: (2024)

Oxymatrine Attenuates Dopaminergic Neuronal Damage and Microglia-Mediated Neuroinflammation Through Cathepsin D-Dependent HMGB1/TLR4/NF-κB Pathway in Parkinson's Disease
by: Ping Gan, et al.
Published: (2020)

<i>Actaea racemosa</i> L. Rhizome Protect against MPTP-Induced Neurotoxicity in Mice by Modulating Oxidative Stress and Neuroinflammation
by: Marika Cordaro, et al.
Published: (2022)

Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson's disease
by: Pathik Parekh, et al.
Published: (2022)

Echinocystic Acid Inhibits Inflammation and Exerts Neuroprotective Effects in MPTP-Induced Parkinson's Disease Model Mice
by: Dewei He, et al.
Published: (2022)

Gypenosides ameliorate memory deficits in MPTP-lesioned mouse model of Parkinson's disease treated with L-DOPA
by: Ting Ting Zhao, et al.
Published: (2017)

Role of Two Efflux Proteins, ABCB1 and ABCG2 in Blood-Brain Barrier Transport of Bromocriptine in a Murine Model of MPTP-Induced Dopaminergic Degeneration
by: Sarah Vautier, et al.
Published: (2009)

Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson's Disease through Activating Mitophagy
by: Ming-Wei Lin, et al.
Published: (2019)

Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson's disease
by: Yi Zhao, et al.
Published: (2018)

Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease
by: Shigeki Hirano
Published: (2021)

Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice
by: Haoyang Wang, et al.
Published: (2023)

Cellular and Molecular Mediators of Neuroinflammation in the Pathogenesis of Parkinson's Disease
by: Sandeep Vasant More, et al.
Published: (2013)